FEATURED/ARCHIVES (30/04/24)
×
Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia: Treatment Adherence, Effectiveness, Tolerability, and Safety · October 2023
Articles
Neuropsychiatric Disease and Treatment
×
Method for Classifying Schizophrenia Patients Based on Machine Learning · June 2023
Articles
Journal of Clinical Medicine
×
Childhood Maltreatment, Educational Attainment, and IQ: Findings from a Multicentric Case-Control Study of First-Episode Psychosis (EU-GEI) · February 2022
Articles
Schizophrenia Bulletin
×
The Polygenic Basis of Relapse After a First Episode of Schizophrenia · August 2023
Articles
European Neuropsychopharmacology
×
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study · June 2023
Articles
JMIR Formative Research
×
Baseline Levels of C-Reactive Protein and Proinflammatory Cytokines Are Not Associated with Early Response to Amisulpride in Patients with First Episode Psychosis: The OPTiMiSE Cohort Study · May 2021
Articles
Schizophrenia Bulletin Open
×
Obesity and Brain Structure in Schizophrenia – ENIGMA Study in 3021 Individuals · June 2022
Articles
Molecular Psychiatry
×
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-Analysis · June 2021
Articles
JAMA Psychiatry
×
Treatment Patterns and Appropriateness of Antipsychotic Prescriptions in Patients with Schizophrenia · June 2021
Articles
Scientific Reports
×
Child Maltreatment, Migration and Risk of First-Episode Psychosis: Results from the Multinational EU-GEI Study · October 2022
Articles
Psychological Medicine
×
Telephone-Delivered Interventions for Suicide Prevention in Schizophrenia and Related Disorders: A Systematic Review · February 2023
Articles
Healthcare
×
Cognitive, Creative, Functional, and Clinical Symptom Improvements in Schizophrenia After an Integrative Cognitive Remediation Program: A Randomized Controlled Trial · October 2021
Articles
NPJ Schizophrenia
×
Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders · November 2022
Articles
Journal of Clinical Medicine
×
Differences between Delusional Disorder and Schizophrenia: A Mini Narrative Review · May 2022
Articles
World Journal of Psychiatry
×
Differential Cellular Interactome in Schizophrenia and Bipolar Disorder-Discriminatory Biomarker Role · November 2023
Articles
Antioxidants
×
Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics · June 2022
Articles
Pharmaceutics
×
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain · April 2022
Articles
CNS Drugs
×
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores than Others: A Cluster Analysis of EU-GEI Data · August 2022
Articles
Schizophrenia Bulletin
×
Free Thyroxin Concentrations Moderate the Response to a Cognitive Remediation Therapy in People with Early Psychosis: Preliminary Findings (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series · July 2022
Articles
Neuropsychiatric Disease and Treatment